Macquarie Group LTD Clear Point Neuro, Inc. Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
84Shares Held
6.83MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$13.6 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$5.07 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$4.1 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$4 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$3.64 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $268M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...